Stock market announcement archive

September 3, 2024
Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraordinary General Meeting 17 September 2024, at 09:00 (CEST). For the planned uplisting from Euronext Growth Oslo to Oslo Børs, a share consolidation is required to meet the NOK 10 per share listing requirement. Additionally, to […]
Read more
August 30, 2024
Reference is made to the Q2 2024 report published by Lifecare ASA (the “Company”) on 27 August 2024. In connection with the uplisting to Euronext Oslo Børs, the Company has conducted new assessments of its financial statements and, in collaboration with its auditor, concluded to recognize the warrants issued in connection with the previously announced […]
Read more
August 27, 2024
Bergen, Norway, 27 August 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q2 financial report and operational update. In the second quarter Lifecare continued to build positive momentum towards automatic production by delivering milestones on a continuous basis over a long […]
Read more
August 13, 2024
Bergen, Norway, August 13, 2024: Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), is pleased to announce a strategic cooperation with OneTwo Analytics AB (OneTwo), a Swedish-based company specializing in data analytics of diabetes data. The strategic cooperation will provide Lifecare access to OneTwo’s portfolio of comprehensive […]
Read more
July 5, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (“Lifecare” or the “Company”) on 14 June 2024 regarding the final results of the partially underwritten rights issue of new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the issuance of 1,377,572 new shares to certain bottom underwriters […]
Read more
July 2, 2024
Reference is made to the previous stock exchange announcements published by Lifecare ASA (the “Company”) regarding the completion of the Rights Issue. Hannibal Invest AS, a company closely associated with Hans Hekland, board member of the Company, has 27 June 2024 subscribed 65,599 shares at a price of NOK 1,52442 per share, as compensation for […]
Read more
June 25, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (“Lifecare” or the “Company”) on 14 June 2024 regarding the final results of the partially underwritten rights issue of new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the issuance of 59,038,955 new shares in the Rights Issue […]
Read more
June 14, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Hannibal Invest AS, a company closely associated with Hans Hekland, board member of the Company, has today subscribed 12.809 shares in […]
Read more
June 14, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more